Immunotherapy in cancer is one of the most interesting and prospective anti-cancer strategies in the oncology, as it uses the patient’s own immune system against cancer cells, thus acting contrary to traditional cancer therapies. The linkage in the fight against different cancers is held by the following treatments: check point inhibitors and CAR T cell therapy however, there are challenges; side effects and resistance. The use of AI and personalized approaches is considered to yield improved results in cancer treatment.
Click here to know more point to point: https://www.europeanhhm.com/articles/present-and-future-outlooks-for-cancer-immunotherapy